Showing results (481-490 of 2,506) with videos related to

Sort By:
Pageof 251
Endocrine-Related Cancer|March 4, 2008
Gastric endocrine tumors type I: treatment with long-acting somatostatin analogsD Campana, F Nori, R Pezzilli, et al.
Endocrine-Related Cancer|March 4, 2008
Overexpression of ERBB-2 was more frequently detected in malignant than benign pheochromocytomas by multiplex ligation-dependent probe amplification and immunohistochemistryWenQi Yuan, WeiQinq Wang, Bin Cui, et al.
Endocrine-Related Cancer|October 23, 2018
Oncometabolite induced primary cilia loss in pheochromocytomaSamuel M O'Toole, David S Watson, Tatiana V Novoselova, et al.
Endocrine-Related Cancer|November 8, 2018
Analysis of the immune landscape of small bowel neuroendocrine tumorsM Cives, J Strosberg, S Al Diffalha, et al.
Endocrine-Related Cancer|February 18, 2017
Cognitive decline in prostate cancer patients undergoing ADT: a potential role for exercise trainingNiamh L Mundell, Robin M Daly, Helen Macpherson, et al.
Endocrine-Related Cancer|February 23, 2017
The EORTC module for quality of life in patients with thyroid cancer: phase IIISusanne Singer, Susan Jordan, Laura D Locati, et al.
Endocrine-Related Cancer|March 1, 2019
Interplay between the androgen receptor signaling axis and microRNAs in prostate cancerRayzel C Fernandes, Theresa E Hickey, Wayne D Tilley, et al.
Endocrine-Related Cancer|July 21, 2019
Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACCAdwitiya Kar, Yu Zhang, Betelehem W Yacob, et al.
Endocrine-Related Cancer|February 2, 2017
Lipomatous tumours in adrenal gland: WHO updates and clinical implicationsAlfred King-Yin Lam
Endocrine-Related Cancer|March 21, 2019
Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysisJoakim Crona, Angela Lamarca, Suman Ghosal, et al.
Pageof 251